Search results
Amgen To Buy Rare Diseases Drugmaker Horizon Therapeutics In $28.3 Billion Deal
Investor's Business Daily· 1 year agoAmgen will buy Horizon Therapeutics for $28.3 billion in the biggest biopharma deal of the year. In...
Is Amgen Stock a Buy Now?
Motley Fool via Yahoo Finance· 6 months agoThis year hasn't been kind to biotech stocks, which as a group haven't kept pace with the broader market. The performance of the SPDR S&P Biotech ETF...
Amgen gets US FTC's go-ahead for $27.8 billion Horizon deal
Reuters via Yahoo Finance· 9 months agoThe U.S. Federal Trade Commission (FTC) has allowed Amgen to continue its $27.8 billion acquisition...
Amgen Sweetens Full-Year Outlook After Narrowly Beating Third-Quarter Forecasts
Investor's Business Daily· 2 years agoAmgen stock popped Friday after the drugmaker sweetened its 2022 outlook following a third-quarter...
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 4 months agoAmgen (AMGN) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might...
Amgen (AMGN) Registers a Bigger Fall Than the Market: Important Facts to Note
Zacks via Yahoo Finance· 6 months agoIn the latest trading session, Amgen (AMGN) closed at $269.35, marking a -0.56% move from the...
Amgen (AMGN) Dips More Than Broader Markets: What You Should Know
Zacks via Yahoo Finance· 2 years agoAmgen (AMGN) closed the most recent trading day at $245.59, moving -0.61% from the previous trading...
Amgen (AMGN) Suffers a Larger Drop Than the General Market: Key Insights
Zacks via Yahoo Finance· 2 months agoIn the latest market close, Amgen (AMGN) reached $264.07, with a -0.59% movement compared to the...
U.S. Supreme Court rules against Amgen bid to revive cholesterol drug patents
Reuters via Yahoo News· 1 year agoWASHINGTON (Reuters) -The U.S. Supreme Court on Thursday ruled against Amgen Inc in its bid to...